Original Article

Enhancing Tobacco Treatment for Medicaid Recipients

Authors: Audrey Darville, PhD, APRN, Lovoria Williams, PhD, FNP-BC, Jean Edward, PhD, RN, Karen Butler, DNP, RN, Kathy Rademacher, BA, Brittney Gray, MS, Clair M. Tischner, MS, Hannah Keeler, MPH, Ellen J. Hahn, PhD, RN

Abstract

Objective: Medicaid recipients are vulnerable to increased morbidity and mortality secondary to high tobacco use prevalence and barriers to accessing tobacco treatment. The purpose of the pilot study was to explore managed care administrators’ perceptions of the facilitators and barriers to tobacco treatment for Medicaid recipients.

Methods: Focus groups with key informants (n = 14) from managed care organizations were conducted in fall 2018. Participants included case, integrated care, quality and field care managers, and individuals working in provider and network relations.

Results: Facilitators to tobacco treatment were universal quality reporting requirements, access to medications, and the role of case management in identifying and engaging tobacco users in treatment. Barriers included bias regarding smokers’ ability to quit, communication challenges, and competing priorities.

Conclusions: The analysis provided data to support the development of a policy brief and recommendations to the Department for Medicaid Services for enhancing tobacco dependence treatment.

This content is limited to qualifying members.

Existing members, please login first.

If you have an existing account please login now to access this article or view your purchase options.

Purchase only this article ($15)

Create a free account, then purchase this article to download or access it online for 24 hours.

Purchase an SMJ online subscription ($75)

Create a free account, then purchase a subscription to get complete access to all articles for a full year.

Purchase a membership plan (fees vary)

Premium members can access all articles plus recieve many more benefits. View all membership plans and benefit packages.

References

1. Xu X, Bishop EE, Kennedy SM, et al. Annual healthcare spending attributable to cigarette smoking: an update. Am J Prev Med 2015;48:326–333.
 
2. Centers for Disease Control and Prevention. Smoking rates for uninsured and adults on Medicaid more than twice those adults with private health insurance. https://www.cdc.gov/media/releases/2015/p1112-smoking-rates.html. Published November 12, 2015. Accessed July 22, 2021.
 
3. DiGiulio A, Jump Z, Yu A, et al. State Medicaid coverage for tobacco cessation treatments and barriers to accessing treatments - United States, 2015-2017. MMWR Morb Mortal Wkly Rep 2018;67:390–395. .
 
4. Medicaid.gov. February 2021 Medicaid & CHIP enrollment data highlights. https://www.medicaid.gov/medicaid/program-information/medicaid-and-chip-enrollment-data/report-highlights/index.html. Published 2021. Accessed July 22, 2021.
 
5. Ku L, Bruen BK, Steinmetz E, et al. Medicaid tobacco cessation: big gaps remain in efforts to get smokers to quit. Health Aff (Millwood) 2016;35: 62–70.
 
6. Fiore MC, Jaen CR, Baker TB, et al. Treating Tobacco Use and Dependence: 2008 Update. Rockville, MD: US Department of Health and Human Services, Public Health Service; 2008.
 
7. Holla N, Brantley E, Ku L. Physicians’ recommendations to Medicaid patients about tobacco cessation. Am J Prev Med 2018;55:762–769.
 
8. US Department of Health and Human Services. Smoking Cessation: A Report of the Surgeon General. Atlanta, GA: Centers for Disease Control and Prevention; 2020.
 
9. Richter KP, Ellerbeck EF. It’s time to change the default for tobacco treatment. Addiction 2015;110:381–386.
 
10. Stead LF, Buitrago D, Preciado N, et al. Physician advice for smoking cessation. Cochrane Database Syst Rev 2013;(5):CD000165.
 
11. Thomsen T, Villebro N, Moller AM. Interventions for preoperative smoking cessation. Cochrane Database Syst Rev 2014;(3):CD002294.
 
12. Khanna P, Clifton AV, Banks D, et al. Smoking cessation advice for people with serious mental illness. Cochrane Database Syst Rev 2016;(1):CD009704.
 
13. Bartsch AL, Harter M, Niedrich J, et al. A systematic literature review of self-reported smoking cessation counseling by primary care physicians. PLoS One 2016;11:e0168482.
 
14. Kotz D, Brown J, West R. “Real-world” effectiveness of smoking cessation treatments: a population study. Addiction 2014;109:491–499.
 
15. McDermott MS, Beard E, Brose LS, et al. Factors associated with differences in quit rates between “specialist” and “community” stop-smoking practitioners in the English stop-smoking services. Nicotine Tob Res 2013;15:1239–1247.
 
16. Song F, Maskrey V, Blyth A, et al. Differences in longer-term smoking abstinence after treatment by specialist or nonspecialist advisors: secondary analysis of data from a relapse prevention trial. Nicotine Tob Res 2016;18:1061–1066.
 
17. Burke MV, Ebbert JO, Schroeder DR, et al. (2015). Treatment outcomes from a specialist model for treating tobacco use disorder in a medical center. Medicine (Baltimore) 2015;94:e1903.
 
18. Land T, Warner D, Paskowsky M, et al. Medicaid coverage for tobacco dependence treatments in Massachusetts and associated decreases in smoking prevalence. PLoS One 2010;5:e9770.
 
19. Centers for Disease Control and Prevention. Extinguishing the tobacco epidemic in Kentucky. https://www.cdc.gov/tobacco/stateandcommunity/state-fact-sheets/kentucky/index.html?CDC_AA_refVal=https%3A%2F%2Fwww.cdc.gov%2Ftobacco%2Fabout%2Fosh%2Fstate-fact-sheets%2Fkentucky%2Findex.html. Published 2019. Accessed July 22, 2021.
 
20. Tobacco Free Kids. The toll of tobacco in Kentucky. 2020. https://www.tobaccofreekids.org/problem/toll-us/kentucky. Published 2020. Accessed July 22, 2021.
 
21. Talbot JA, Williamson ME, Pearson KB, et al. Advancing Tobacco Prevention and Control in Rural America. Washington, DC: National Network of Public Health Institutes; 2019.
 
22. Kentucky Medicaid Tracker. County-by-county Medicaid enrollment. https://kymedicaidtracker.com/. Accessed July 22, 2021.
 
23. Wang TW, Asman K, Gentzke AS, et al. Tobacco product use among adults - United States, 2017. MMWR Morb Mortal Wkly Rep 2018;67:1225–1232.
 
24. Kruger J, O’Halloran A, Rosenthal AC, et al. Receipt of evidence-based brief cessation interventions by health professionals and use of cessation assisted treatments among current adult cigarette-only smokers: National Adult Tobacco Survey, 2009-2010. BMC Public Health 2016;16:141.
 
25. Tong VT, England LJ, Malarcher A, et al. Clinicians’ awareness of the Affordable Care Act mandate to provide comprehensive tobacco cessation treatment for pregnant women covered by Medicaid. Prev Med Rep 2015;2:686–688.
 
26. National Committee for Quality Assurance. Medical assistance with smoking and tobacco use cessation (MSC). https://www.ncqa.org/hedis/measures/medical-assistance-with-smoking-and-tobacco-use-cessation/. Accessed July 22, 2021.
 
27. Samet JM. Tobacco smoking: the leading cause of preventable disease worldwide. Thorac Surg Clin 2013;23:103–112.
 
28. Tibuakuu M, Okunrintemi V, Jirru E, et al. National trends in cessation counseling, prescription medication use, and associated costs among US adult cigarette smokers. JAMA Netw Open 2019;2:e194585.
 
29. Twyman L, Bonevski B, Paul C, et al. Perceived barriers to smoking cessation in selected vulnerable groups: a systematic review of the qualitative and quantitative literature. BMJ Open 2014;4:e006414.